These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18439227)

  • 1. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis.
    Slade A; Stanic S
    J Neurol Sci; 2015 May; 352(1-2):34-6. PubMed ID: 25881952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.
    Bourry N; Guy N; Achard JL; Verrelle P; Clavelou P; Lapeyre M
    Cancer Radiother; 2013 Jun; 17(3):191-5. PubMed ID: 23517881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptomatic treatments in amyotrophic lateral sclerosis].
    Clavelou P; Guy N
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S228-4S234. PubMed ID: 17128116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Salivary management in amyotrophic lateral sclerosis].
    Fries S; Schweizer V
    Rev Med Suisse; 2018 Oct; 14(621):1758-1762. PubMed ID: 30303328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral parotid electron beam radiotherapy as palliative treatment for sialorrhea in amyotrophic lateral sclerosis.
    Kasarskis EJ; Hodskins J; St Clair WH
    J Neurol Sci; 2011 Sep; 308(1-2):155-7. PubMed ID: 21726879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Sialorrhea Among Amyotrophic Lateral Sclerosis Patients: A Systematic Review and Meta-Analysis.
    Wang Y; Yang X; Han Q; Liu M; Zhou C
    J Pain Symptom Manage; 2022 Apr; 63(4):e387-e396. PubMed ID: 34920148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis.
    Harriman M; Morrison M; Hay J; Revonta M; Eisen A; Lentle B
    J Otolaryngol; 2001 Aug; 30(4):242-5. PubMed ID: 11771037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis.
    Cooper-Knock J; Ahmedzai SH; Shaw P
    Amyotroph Lateral Scler; 2011 Nov; 12(6):464-5. PubMed ID: 21554032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead.
    Blackhall LJ
    Muscle Nerve; 2012 Mar; 45(3):311-8. PubMed ID: 22334165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.